Lawton Alison Frances 4
4 · Magenta Therapeutics, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-01+18,188→ 18,188 totalExercise: $12.91Exp: 2031-05-31→ Common Stock (18,188 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders.